Will Humans Live Beyond 100? Russia Bets on Science of Aging
News Desk
MOSCOW: Could humanity one day overcome the biological limits of aging—and perhaps even approach immortality? Maria Vorontsova, the eldest daughter of Russian President Vladimir Putin and an endocrinologist, has suggested that advances in medical science could bring radical life extension closer to reality in the coming decades.
Speaking at an event in Moscow titled ‘Live Long, Live Differently’, Vorontsova reportedly argued that growing human anxiety about death could drive the healthcare sector to pursue new scientific solutions over the next 10 to 20 years. She heads the Medical Research and Education Institute at Moscow State University.
Vorontsova outlined a two-stage approach to extending human life. The first involves established health measures, including a balanced diet, regular physical activity and limited alcohol consumption, which can help people maintain their health into old age. The second would require major medical breakthroughs capable of slowing or overcoming the biological processes associated with aging.
While healthy habits can improve longevity and quality of life, extending the human lifespan far beyond its current limits remains a much greater scientific challenge.
Putin’s interest in longevity
Interest in life extension also appears at the highest levels of the Russian government. Putin has discussed the potential of biotechnology, regenerative medicine and organ replacement to extend healthy and active life.
During a meeting with Chinese President Xi Jinping in Beijing in 2025, the two leaders were reportedly overheard discussing aging and the possibility of humans living to 150. Putin subsequently remarked that advances in modern medicine and organ transplantation could allow people to remain active for considerably longer.
The discussions have drawn attention to the growing international interest in longevity research, which seeks not only to extend life but also to delay age-related diseases and preserve physical and cognitive function.
Russia invests in health technologies
In 2024, the Russian government announced a national initiative reportedly worth $26 billion, titled ‘New Technologies for Health Preservation’. The programme aims to improve healthcare and increase average life expectancy, including through research into genetic and cellular treatments intended to slow aging.
Russia’s Kurchatov Institute is also reported to be conducting research into 3D bioprinting, a technology that could eventually help produce biological tissues and, potentially, functional organs. Other research efforts are exploring gene therapies and cellular interventions that might reduce the effects of age-related deterioration.
Such technologies could have important medical applications if researchers can demonstrate that they are safe, effective and capable of producing lasting benefits in humans.
The scientific limits of immortality
Despite growing investment and public interest, scientific progress has yet to establish a reliable way to stop human aging. Research into longevity faces substantial challenges, including the complexity of age-related diseases, the risk of cancer associated with certain cellular interventions and the difficulty of translating laboratory discoveries into safe treatments.
The frequently cited upper limit of the human lifespan is around 120 to 125 years, although the precise biological ceiling remains debated. The development of fully functional, transplantable organs through 3D bioprinting also remains a work in progress.
The debate over longevity research has raised questions about the allocation of public funds, particularly as Russia continues its war in Ukraine and faces competing economic and social priorities.
For now, extending healthy life expectancy remains a more realistic scientific objective than achieving immortality. Advances in preventive medicine, regenerative therapies and the treatment of age-related diseases may help people live longer and healthier lives, but a complete victory over death remains speculative.
